Logo image of IVDA

IVEDA SOLUTIONS INC (IVDA) Stock Fundamental Analysis

USA - NASDAQ:IVDA - US46583A3032 - Common Stock

1.42 USD
-0.03 (-2.07%)
Last: 9/15/2025, 1:26:58 PM
Fundamental Rating

2

Taking everything into account, IVDA scores 2 out of 10 in our fundamental rating. IVDA was compared to 280 industry peers in the Software industry. IVDA may be in some trouble as it scores bad on both profitability and health. IVDA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IVDA has reported negative net income.
In the past year IVDA has reported a negative cash flow from operations.
In the past 5 years IVDA always reported negative net income.
In the past 5 years IVDA always reported negative operating cash flow.
IVDA Yearly Net Income VS EBIT VS OCF VS FCFIVDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M -5M

1.2 Ratios

IVDA has a worse Return On Assets (-80.96%) than 89.29% of its industry peers.
The Return On Equity of IVDA (-215.55%) is worse than 81.79% of its industry peers.
Industry RankSector Rank
ROA -80.96%
ROE -215.55%
ROIC N/A
ROA(3y)-58.84%
ROA(5y)-80.97%
ROE(3y)-97.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVDA Yearly ROA, ROE, ROICIVDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

IVDA's Gross Margin of 19.70% is on the low side compared to the rest of the industry. IVDA is outperformed by 82.50% of its industry peers.
In the last couple of years the Gross Margin of IVDA has declined.
The Profit Margin and Operating Margin are not available for IVDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.62%
GM growth 5Y-5.06%
IVDA Yearly Profit, Operating, Gross MarginsIVDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

IVDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IVDA has more shares outstanding
Compared to 5 years ago, IVDA has more shares outstanding
IVDA has a worse debt/assets ratio than last year.
IVDA Yearly Shares OutstandingIVDA Yearly Shares OutstandingYearly Shares Outstanding 2015 2019 2020 2021 2022 2023 2024 5M 10M 15M
IVDA Yearly Total Debt VS Total AssetsIVDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -16.44, we must say that IVDA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IVDA (-16.44) is worse than 92.14% of its industry peers.
IVDA has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.47, IVDA is doing worse than 65.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -16.44
ROIC/WACCN/A
WACC10.52%
IVDA Yearly LT Debt VS Equity VS FCFIVDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

IVDA has a Current Ratio of 1.80. This is a normal value and indicates that IVDA is financially healthy and should not expect problems in meeting its short term obligations.
IVDA has a Current ratio of 1.80. This is comparable to the rest of the industry: IVDA outperforms 57.14% of its industry peers.
IVDA has a Quick Ratio of 1.71. This is a normal value and indicates that IVDA is financially healthy and should not expect problems in meeting its short term obligations.
IVDA's Quick ratio of 1.71 is in line compared to the rest of the industry. IVDA outperforms 55.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.71
IVDA Yearly Current Assets VS Current LiabilitesIVDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

IVDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.55%.
IVDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 54.30%.
Measured over the past years, IVDA shows a quite strong growth in Revenue. The Revenue has been growing by 10.59% on average per year.
EPS 1Y (TTM)-23.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.46%
Revenue 1Y (TTM)54.3%
Revenue growth 3Y46.37%
Revenue growth 5Y10.59%
Sales Q2Q%326.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year229.89%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVDA Yearly Revenue VS EstimatesIVDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IVDA Yearly EPS VS EstimatesIVDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IVDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
IVDA is valuated cheaply with a Price/Forward Earnings ratio of 6.05.
Based on the Price/Forward Earnings ratio, IVDA is valued cheaply inside the industry as 96.79% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.73. IVDA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.05
IVDA Price Earnings VS Forward Price EarningsIVDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVDA Per share dataIVDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

IVDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IVEDA SOLUTIONS INC

NASDAQ:IVDA (9/15/2025, 1:26:58 PM)

1.42

-0.03 (-2.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners2.98%
Inst Owner Change28.75%
Ins Owners4.74%
Ins Owner Change0%
Market Cap4.13M
Analysts82.86
Price TargetN/A
Short Float %1.1%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.61%
Min Revenue beat(2)-85.34%
Max Revenue beat(2)-69.88%
Revenue beat(4)0
Avg Revenue beat(4)-50.25%
Min Revenue beat(4)-85.34%
Max Revenue beat(4)-5.95%
Revenue beat(8)0
Avg Revenue beat(8)-55.35%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.05
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 2.43
P/tB 2.43
EV/EBITDA N/A
EPS(TTM)-1.48
EYN/A
EPS(NY)0.23
Fwd EY16.52%
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS2.46
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.96%
ROE -215.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.7%
FCFM N/A
ROA(3y)-58.84%
ROA(5y)-80.97%
ROE(3y)-97.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.62%
GM growth 5Y-5.06%
F-Score3
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.71
Altman-Z -16.44
F-Score3
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)163.5%
Cap/Depr(5y)131.43%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.46%
EPS Next Y264.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)54.3%
Revenue growth 3Y46.37%
Revenue growth 5Y10.59%
Sales Q2Q%326.18%
Revenue Next Year229.89%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.19%
OCF growth 3YN/A
OCF growth 5YN/A